Clinical trial
Safe Use of New Oral Anticoagulants in Patients Treated by Catheter Ablation for Atrial Fibrillation
NCT02569255 is registered in ClinicalTrials.gov with Private Hospital Heart Center Varde as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safe Use of New Oral Anticoagulants in Patients Treated by Catheter Ablation for Atrial Fibrillation
- Lead sponsor
- Private Hospital Heart Center Varde
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- June 30, 2015
- Enrollment
- 234 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.